Characterization of the metabolic phenotype of chronically activated lymphocytes.
about
Metabolic reprogramming and metabolic dependency in T cellsMitochondria in the regulation of innate and adaptive immunityThe role of Fatty Acid oxidation in the metabolic reprograming of activated t-cellsMetabolic control of the epigenome in systemic Lupus erythematosus.Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cellsT-cell metabolism in autoimmune disease.Deranged bioenergetics and defective redox capacity in T lymphocytes and neutrophils are related to cellular dysfunction and increased oxidative stress in patients with active systemic lupus erythematosus.Metabolic pathways in T cell fate and function.Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease.Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation.Glucose Oxidation Is Critical for CD4+ T Cell Activation in a Mouse Model of Systemic Lupus Erythematosus.Metabolic regulation of T lymphocytes.Changing the energy of an immune responseMetabolic Factors that Contribute to Lupus PathogenesisNormalization of CD4+ T cell metabolism reverses lupusmTOR, metabolism, and the regulation of T-cell differentiation and function.T-cell metabolism governing activation, proliferation and differentiation; a modular view.Immune Cell Metabolism in Systemic Lupus Erythematosus.Lactate at the crossroads of metabolism, inflammation, and autoimmunity.Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation.Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence.Immunometabolism in systemic lupus erythematosus.Fine tuning of immunometabolism for the treatment of rheumatic diseases.Metabolic abnormalities and oxidative stress in lupus.Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantationMitochondria, Bioenergetics and Excitotoxicity: New Therapeutic Targets in Perinatal Brain InjuryFree radicals and redox signalling in T-cells during chronic inflammation and ageing.Influence of Inflammation in the Process of T Lymphocyte Differentiation: Proliferative, Metabolic, and Oxidative Changes.T-Cell Metabolism in Hematopoietic Cell Transplantation.Metformin and Autoimmunity: A "New Deal" of an Old Drug.Changes in Nutritional Status Impact Immune Cell Metabolism and Function.Long-term antigen exposure irreversibly modifies metabolic requirements for T cell function.
P2860
Q26864319-DA2BE8FB-7075-47BF-AF03-69157792FB4DQ26992186-8DDEC594-B2B9-438B-9ED8-09DF87F1B3BFQ28080686-2284B95C-2D21-433B-9735-8F390231EA49Q33664849-3F9FB1C3-95CB-4451-B784-2D523F668BECQ33911139-A4E1B90D-EF2C-4CDC-BB67-043592227FACQ35071556-AFE6F47B-C0DC-49F8-AC8B-2F3686E512EFQ35326330-D5EB3213-D1EC-42EE-B4E7-B84EA609EE42Q35870766-7EBA1AB9-F254-4F8A-93C7-1BD63B2F2D5BQ35998783-62BBC5E6-4138-4AE1-BF2B-584636041CE8Q36174985-0B70AD32-6306-4FC6-AB89-AB2366A6AA80Q36387092-76EBE2C2-B618-4112-AC3B-7C956C90BF92Q36711431-B5AF5BA2-D904-402C-9B1D-C3FA2EBA56C9Q37021691-8B337E24-499D-4EE8-BB29-712D9B878718Q37612885-58700CB3-5D31-4588-B755-E32F1B2E6690Q37625717-4F4643C2-3DD5-42F5-9959-73300B30C8DDQ38034265-600D3399-3124-45CF-9473-3C5E85564730Q38915095-98CECEA4-B77B-4E4A-89B8-851B19C55BABQ38973345-A58148B0-3690-4ACD-B51A-44F03FCDD142Q39018716-8E209352-4CB8-4375-AD01-D1D3ED9DE9BBQ39099620-E0A03224-523A-4B22-8D69-8BC19DAE9225Q39110118-A607FEBC-DBEB-49F4-85A1-EB762E57A6A5Q39209701-F0E3241E-BF96-4B6C-B69A-0BDF61CD25C5Q39223057-24808A67-832F-49EF-8D96-EB7183A5BA72Q39390654-55F7DC0F-02E5-4C6C-AF1D-6918CBD66858Q39617623-15E3A75E-2572-4617-A898-F1B0F64BE8ECQ40987303-57882D4B-CFB0-4E82-ACA3-D7E2BF0A382FQ42494792-4652C333-33CD-4A77-8589-BE6DBD31B2D9Q51733559-5B757F3F-DFDD-4D8A-AD84-FDC8DAF9469BQ52686035-2A4DE4B7-DA00-4FC2-98C9-56D775447436Q55240881-01E4B6EC-2CF9-4CBF-BE24-68A0795614A9Q55262568-5FA76EE1-0953-4BA5-932B-31F541EC3934Q55425735-0554F398-664D-4399-9E2A-152028185E51
P2860
Characterization of the metabolic phenotype of chronically activated lymphocytes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Characterization of the metabolic phenotype of chronically activated lymphocytes.
@en
Characterization of the metabolic phenotype of chronically activated lymphocytes.
@nl
type
label
Characterization of the metabolic phenotype of chronically activated lymphocytes.
@en
Characterization of the metabolic phenotype of chronically activated lymphocytes.
@nl
prefLabel
Characterization of the metabolic phenotype of chronically activated lymphocytes.
@en
Characterization of the metabolic phenotype of chronically activated lymphocytes.
@nl
P2093
P2860
P356
P1433
P1476
Characterization of the metabolic phenotype of chronically activated lymphocytes.
@en
P2093
A W Opipari
B C Richardson
B Petersen
P2860
P304
P356
10.1177/0961203310373109
P577
2010-07-20T00:00:00Z